Reuters – 3SBio to be Taken Private
Chinese biotechnology firm 3SBio agreed to be taken private for about $340 million by a group led by its chief executive Jing Lou and Chinese private equity firm CITIC Private Equity, the latest in a growing list of Chinese companies going private to escape U.S. regulatory scrutiny, Reuters reported. The CITIC consortium's offer price of $15.40 for each 3SBio American Depositary Share is at a premium of about 12 percent to the ADS's Thursday close of $13.79.
14 February 2013•2 mins read
